Veru (VERU) closed at $2.12 on November 6, 2026, up 2.9% from the previous close, on volume of 136,034 shares (30-day average 188,844).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 13, 2026 | Call Spread | 16-Oct-260.5 : 1 C | 2,218 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
Globe Newswire (Tue, 8-Sep 8:17 AM ET)
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
Globe Newswire (Wed, 2-Sep 8:30 AM ET)
Globe Newswire (Mon, 10-Aug 6:30 AM ET)
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
Veru trades on the NASDAQ stock market under the symbol VERU.
As of November 6, 2026, VERU stock price climbed to $2.12 with 136,034 million shares trading.
VERU has a beta of 1.41, meaning it tends to be more sensitive to market movements. VERU has a correlation of 0.06 to the broad based SPY ETF.
VERU has a market cap of $36.15 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, VERU traded as high as $19.20 and as low as $2.04.
The top ETF exchange traded funds that VERU belongs to (by Net Assets): VTI, VXF, IWC.
VERU has underperformed the market in the last year with a price return of -15.9% while the SPY ETF gained +10.8%. VERU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.2% and -5.4%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
VERU support price is $1.96 and resistance is $2.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VERU shares will trade within this expected range on the day.
